Items where authors include "Mistry, A"

Article

Walker, K orcid.org/0000-0002-6694-2979, Mistry, A, Watson, CM et al. (9 more authors) (2023) Inherited CD19 Deficiency Does Not Impair Plasma Cell Formation or Response to CXCL12. Journal of Clinical Immunology, 43. pp. 1543-1556. ISSN 0271-9142

Denman, S, Smith, H, Arumugakani, G et al. (2 more authors) (2022) Cost effectiveness of personalised omalizumab dosing for chronic spontaneous urticaria. Clinical and Experimental Dermatology, 47 (11). pp. 2002-2005. ISSN 0307-6938

Savic, S orcid.org/0000-0001-7910-0554, Mistry, A, Wilson, AG et al. (4 more authors) (2017) Autoimmune-autoinflammatory rheumatoid arthritis overlaps: a rare but potentially important subgroup of diseases. RMD Open, 3. e000550. ISSN 2056-5933

Mistry, A, Scambler, T, Parry, D et al. (5 more authors) (2017) Glucose-6-Phosphatase Catalytic Subunit 3 (G6PC3) Deficiency Associated With Autoinflammatory Complications. Frontiers in Immunology, 8. 1485. ISSN 1664-3224

Lawless, D orcid.org/0000-0001-8496-3725, Mistry, A, Wood, PM et al. (7 more authors) (2017) Bialellic Mutations in Tetratricopeptide Repeat Domain 7A (TTC7A) Cause Common Variable Immunodeficiency-Like Phenotype with Enteropathy. Journal of Clinical Immunology, 37 (7). pp. 617-622. ISSN 0271-9142

Mistry, A, Savic, S and van der Hilst, JCH (2017) Interleukin-1 Blockade: An Update on Emerging Indications. BioDrugs, 31 (3). pp. 207-221. ISSN 1173-8804

Denman, S, Ford, K, Toolan, J et al. (4 more authors) (2016) Home Self-Administration of Omalizumab for Chronic Spontaneous Urticaria. British Journal of Dermatology, 175 (6). pp. 1405-1407. ISSN 0007-0963

Mistry, A, Parry, D, Matthews, B et al. (3 more authors) (2016) A Case of SLC29A3 Spectrum Disorder—Unresponsive to Multiple Immunomodulatory Therapies. Journal of Clinical Immunology, 36 (5). pp. 429-433. ISSN 0271-9142

Conference or Workshop Item

Corps, C, Denman, S, Ford, K et al. (5 more authors) (2017) Short course specific immunotherapy for seasonal allergic rhinoconjunctivitis and its impact on quality of life. In: European Academy of Allergy and Clinical Immunology Congress (EAACI 2017), 17-21 Jun 2017, Helsinki, Finland.

Denman, S, Toolan, J, Ford, K et al. (5 more authors) (2017) The impact of the introduction of icatibant on A&E attendance, hospital admissions and acute treatment episodes in patients with hereditary angioedema. In: European Academy of Allergy and Clinical Immunology Congress (EAACI 2017), 17-21 Jun 2017, Helsinki, Finland.